Alibaba Cloud retains top spot in China game cloud market for 5th year
The company led both the infrastructure and solutions segments in the second half of 2025, with market shares of 39% and 42%, respectively.
Month: April 2026
Read More
Westlake University develops plant-based plastic alternative to replace PET
A one-million-tonne-class HMF production facility in Zhejiang was structurally completed in December, laying groundwork for potential scaling of plant-based plastics.
Cainiao unveils climbing warehouse robot to speed up automated logistics
The launch underscores a broader ongoing shift in logistics automation from isolated task-based systems toward coordinated, AI-managed operations spanning the full warehouse workflow.
Weimai expands into AI-driven cardiac care with new agent launch
However, fragmented follow-up systems and limited post-discharge tracking have long been cited as weaknesses in standard care pathways.
Qwen launches S1 AI glasses as global wearables race heats up
The launch comes weeks after Qwen’s earlier G1 model captured more than 70% of China’s online AI glasses segment in its first week on sale, market data show.
WeDoctor chairman says AI agents to reshape healthcare delivery
WeDoctor, a unicorn headquartered in Hangzhou, has been building out its own AI-driven healthcare network through partnerships with local governments.
Geely-backed chipmaker Geener posts 300% surge in Q1 on EV boom
The technology has long been dominated by suppliers such as Infineon Technologies and onsemi, with local suppliers historically accounting for less than 20% of the market.
Manycore IPO draws over 1,000x demand ahead of Hong Kong debut
The Hangzhou-based company’s public tranche was oversubscribed about 1,071 times, with total margin financing and subscriptions reaching HK$131.2 billion ($16.75 billion).
AI model developer Shengshu partners Alibaba Cloud to expand video tools
The collaboration spans the full AI stack, including data processing, model training, inference acceleration and application deployment.
Zhejiang University study finds path to non-addictive pain relief drug
Cannabinoid compounds are known to be effective in treating conditions such as chronic pain, anxiety and epilepsy, but their clinical use has been constrained by risks of addiction and other side effects.